Liting Zhai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liting Zhai has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Can Cui
Musculoskeletal Research Laboratory, Department of Orthopaedics and Traumatology, the Chinese University of Hong Kong, Hong Kong SAR, China
1 shared publication - Luochenxi Mou
Musculoskeletal Research Laboratory, Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China
1 shared publication - Ning Zhang
Department of Orthopaedics and Traumatology, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region of China
1 shared publication - Qianjin Wang
Musculoskeletal Research Laboratory, Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Hong Kong SAR, China
1 shared publication - Ronald Man Yeung Wong
Department of Orthopaedics and Traumatology, the Chinese University of Hong Kong, Hong Kong, China
1 shared publication Wenxin Zhang
The Chinese University of Hong Kong
1 shared publication
Latest Publications
- Open Access
Artificial Intelligence Across the Sarcopenia Care Pathway: From Opportunistic Screening to Intelligent Rehabilitation
Sarcopenia is a progressive, age-related skeletal muscle disorder that serves as a driver of frailty, falls, and mortality in older adults. Despite the recent paradigm shift introduced by the latest sarcopenia consensus, which emphasizes early, proactive detection, sarcopenia cases frequently evade traditional screening due to inherent diagnostic bottlenecks and resource limitations. Artificial intelligence has emerged as a transformative solution to dismantle these barriers across the entire continuum of sarcopenia care. This review explores the rapid evolution of artificial intelligence, beginning with automated opportunistic screening that extracts prognostic musculoskeletal data from routine imaging and electronic health records, advancing toward high-precision multimodal assessment architectures. Beyond initial assessment, artificial intelligence is actively restructuring longitudinal care by the integration of ubiquitous wearables, Large Language Models, and computer vision, enabling dynamic exercise prescriptions and real-time kinematic postural correction for sarcopenia rehabilitation. Realizing this potential requires the medical community to confront urgent clinical barriers, including multi-center validation, semantic interoperability, health economic justification, and the strict preservation of human-centric ethics. By addressing these challenges, this review provides a definitive roadmap for embedding artificial intelligence across the entire sarcopenia care pathway, transforming isolated instances of opportunistic screening into a unified ecosystem for intelligent, proactive rehabilitation.
Open AccessArtificial Intelligence Across the Sarcopenia Care Pathway: From Opportunistic Screening to Intelligent Rehabilitation
Sarcopenia is a progressive, age-related skeletal muscle disorder that serves as a driver of frailty, falls, and mortality in older adults. Despite the recent paradigm shift introduced by the latest sarcopenia consensus, which emphasizes early, proactive detection, sarcopenia cases frequently evade traditional screening due to inherent diagnostic bottlenecks and resource limitations. Artificial intelligence has emerged as a transformative solution to dismantle these barriers across the entire continuum of sarcopenia care. This review explores the rapid evolution of artificial intelligence, beginning with automated opportunistic screening that extracts prognostic musculoskeletal data from routine imaging and electronic health records, advancing toward high-precision multimodal assessment architectures. Beyond initial assessment, artificial intelligence is actively restructuring longitudinal care by the integration of ubiquitous wearables, Large Language Models, and computer vision, enabling dynamic exercise prescriptions and real-time kinematic postural correction for sarcopenia rehabilitation. Realizing this potential requires the medical community to confront urgent clinical barriers, including multi-center validation, semantic interoperability, health economic justification, and the strict preservation of human-centric ethics. By addressing these challenges, this review provides a definitive roadmap for embedding artificial intelligence across the entire sarcopenia care pathway, transforming isolated instances of opportunistic screening into a unified ecosystem for intelligent, proactive rehabilitation.
- 9 August 2024
- Published by Springer Nature
- Vol. 2841, 215-224
Determination of the Cryo-EM Structure of ATG9 from Arabidopsis thaliana
Macroautophagy/autophagy is a highly conserved process for the degradation of cellular components and plays an essential role in cellular homeostasis maintenance. During autophagy, specialized double-membrane vesicles known as autophagosomes are formed and sequester cytoplasmic cargoes and deliver them to lysosomes or vacuoles for breakdown. Central to this process are autophagy-related (ATG) proteins, with the ATG9—the only integral membrane protein in this core machinery—playing a central role in mediating autophagosome formation. Recent years have witnessed the maturation of cryo-electron microscopy (cryo-EM) and single-particle analysis into powerful tools for high-resolution structural determination of protein complexes. These advancements have significantly deepened our understanding of the intricate molecular mechanisms underlying autophagosome biogenesis. In this study, we present a protocol detailing the acquisition of the three-dimensional structure of ATG9 from Arabidopsis thaliana. The structural resolution achieved 7.8 Å determined by single-particle cryo-electron microscopy (cryo-EM).
- 9 August 2024
- Published by Springer Nature
- Vol. 2841, 215-224
Determination of the Cryo-EM Structure of ATG9 from Arabidopsis thaliana
Macroautophagy/autophagy is a highly conserved process for the degradation of cellular components and plays an essential role in cellular homeostasis maintenance. During autophagy, specialized double-membrane vesicles known as autophagosomes are formed and sequester cytoplasmic cargoes and deliver them to lysosomes or vacuoles for breakdown. Central to this process are autophagy-related (ATG) proteins, with the ATG9—the only integral membrane protein in this core machinery—playing a central role in mediating autophagosome formation. Recent years have witnessed the maturation of cryo-electron microscopy (cryo-EM) and single-particle analysis into powerful tools for high-resolution structural determination of protein complexes. These advancements have significantly deepened our understanding of the intricate molecular mechanisms underlying autophagosome biogenesis. In this study, we present a protocol detailing the acquisition of the three-dimensional structure of ATG9 from Arabidopsis thaliana. The structural resolution achieved 7.8 Å determined by single-particle cryo-electron microscopy (cryo-EM).